BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Increasing rates of obesity and diabetes have driven corresponding increases in related
cardiorenal and metabolic diseases. In many patients, these conditions occur together …

Background Elevated coronary artery calcium (CAC) scores in subjects without prior
atherosclerotic cardiovascular disease (ASCVD) have been shown to be associated with …

Background Implementation of semaglutide weight loss therapy has been challenging due
to drug supply and cost, underscoring a need to identify those who derive the greatest …

Management of elevated low‐density lipoprotein cholesterol (LDL‐C) is central to
preventing atherosclerotic cardiovascular disease (ASCVD) and key to reducing the risk of …

Determining optimal candidates for the numerous potential pharmacotherapies for primary
prevention of atherosclerotic cardiovascular disease remains challenging. Selective use of …

Coronary artery calcium (CAC) is a direct measure of an individual's coronary
atherosclerotic burden. Higher levels of CAC are strongly associated with an increased risk …

Atherosclerotic cardiovascular disease risk (ASCVD) is an ongoing epidemic, and lipid
abnormalities are its primordial cause. Most individuals suffering a first ASCVD event are …

American Heart Association Primary Prevention Guideline recommends the selective use of
coronary artery calcium (CAC) scoring in primary prevention to aid in decision making …